About Sera Prognostics

Sera is a women’s health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera provides pivotal information during pregnancy to physicians, designed to help improve the health of their patients, and to reduce the costs of healthcare delivery. Sera has a robust pipeline of innovative diagnostic tests focused on the prediction of preterm birth risk and other complications of pregnancy. Sera is the first to launch a simple blood test (PreTRM®) that biologically identifies, and reports, to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk. The higher the risk identified through PreTRM® directly correlates to earlier gestational age of birth. Early identification, and appropriate evidence-based treatment, help to prolong gestational age and improve newborn health. Even modest increases in gestational age can have profoundly positive effects on health and economic outcomes. Sera Prognostics is located in Salt Lake City, Utah.